A risk classification for immunosuppressive treatment-associated progressive multifocal leukoencephalopathy
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A risk classification for immunosuppressive treatment-associated progressive multifocal leukoencephalopathy
Authors
Keywords
Progressive multifocal leukoencephalopathy, Natalizumab, Efalizumab, Rituximab, Mycophenolate mofetil
Journal
JOURNAL OF NEUROVIROLOGY
Volume 21, Issue 6, Pages 623-631
Publisher
Springer Nature
Online
2014-11-21
DOI
10.1007/s13365-014-0303-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-TNF Agents as Therapeutic Choice in Immune-Mediated Inflammatory Diseases: Focus on Adalimumab
- (2017) A. Armuzzi et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Specific loss of cellular L-selectin on CD4+ T cells is associated with progressive multifocal leukoencephalopathy development during HIV infection
- (2014) Tilman Schneider-Hohendorf et al. AIDS
- Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy
- (2014) Tatiana Plavina et al. ANNALS OF NEUROLOGY
- Natalizumab Risk Stratification: Role of a Two- Step Anti-JCV Antibody Assay
- (2014) Paul W. O'Connor CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- Alemtuzumab for the treatment of relapsing–remitting multiple sclerosis
- (2014) Carrie M Hersh et al. Immunotherapy
- A case of progressive multifocal leukoencephalopathy in a lupus patient treated with belimumab
- (2014) CA Fredericks et al. LUPUS
- JC virus antibody status underestimates infection rates
- (2013) Joseph R. Berger et al. ANNALS OF NEUROLOGY
- A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification
- (2013) Peter Lee et al. JOURNAL OF CLINICAL VIROLOGY
- L-Selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients
- (2013) N. Schwab et al. NEUROLOGY
- PML in a Patient Treated with Dimethyl Fumarate from a Compounding Pharmacy
- (2013) Bob W. van Oosten et al. NEW ENGLAND JOURNAL OF MEDICINE
- Manufacturer's Response to Case Reports of PML
- (2013) Marianne T. Sweetser et al. NEW ENGLAND JOURNAL OF MEDICINE
- PML in a Patient Treated with Fumaric Acid
- (2013) Ummehan Ermis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: Evolving role of biologic therapies
- (2012) Eamonn S. Molloy et al. ARTHRITIS AND RHEUMATISM
- Progressive multifocal leukoencephalopathy in autoimmune diseases
- (2012) Elisabeth Palazzo et al. JOINT BONE SPINE
- The discovery of natalizumab, a potent therapeutic for multiple sclerosis
- (2012) Lawrence Steinman JOURNAL OF CELL BIOLOGY
- Progressive multifocal leukoencephalopathy in a patient with Hodgkin lymphoma treated with brentuximab vedotin
- (2012) Nina D. Wagner-Johnston et al. LEUKEMIA & LYMPHOMA
- Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab
- (2012) Per Soelberg Sørensen et al. Multiple Sclerosis Journal
- Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
- (2012) Robert J. Fox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
- (2012) Ralf Gold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab-Associated Progressive Multifocal Leukoencephalopathy in Rheumatoid Arthritis
- (2011) David B. Clifford ARCHIVES OF NEUROLOGY
- Immune mechanisms of new therapeutic strategies in multiple sclerosis—A focus on alemtuzumab
- (2011) Luisa Klotz et al. CLINICAL IMMUNOLOGY
- Progressive multifocal leukoencephalopathy associated with efalizumab use in psoriasis patients
- (2011) Namita Kothary et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy
- (2011) P. Vermersch et al. NEUROLOGY
- Alemtuzumab Induction in Renal Transplantation
- (2011) Michael J. Hanaway et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-JC virus antibodies: Implications for PML Risk Stratification
- (2010) Leonid Gorelik et al. ANNALS OF NEUROLOGY
- Natalizumab and Progressive Multifocal Leukoencephalopathy
- (2010) Clemens Warnke et al. ARCHIVES OF NEUROLOGY
- A case of progressive multifocal leukoencephalopathy in a patient treated with infliximab
- (2010) Deepak Kumar et al. ARTHRITIS AND RHEUMATISM
- Progressive Multifocal Leukoencephalopathy and Newer Biological Agents
- (2010) Joseph R. Berger DRUG SAFETY
- Characterization of JC human polyomavirus infection in a Portuguese population
- (2010) Ana Matos et al. JOURNAL OF MEDICAL VIROLOGY
- Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
- (2010) Volker Brinkmann et al. NATURE REVIEWS DRUG DISCOVERY
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of long-term belimumab treatment on b cells in systemic lupus erythematosus: Extension of a phase II, double-blind, placebo-controlled, dose-ranging study
- (2009) Annett M. Jacobi et al. ARTHRITIS AND RHEUMATISM
- Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project
- (2009) K. R. Carson et al. BLOOD
- Progressive Multifocal Leukoencephalopathy Following Heightened Immunosuppression After Lung Transplant
- (2009) Jesse Waggoner et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Decrease in the Numbers of Dendritic Cells and CD4+ T Cells in Cerebral Perivascular Spaces Due to Natalizumab
- (2008) Maria del Pilar Martin ARCHIVES OF NEUROLOGY
- Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: Are patients with systemic lupus erythematosus at particular risk?
- (2008) Eamonn S. Molloy et al. AUTOIMMUNITY REVIEWS
- A review of the current use of rituximab in autoimmune diseases
- (2008) Hakan M. Gürcan et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients
- (2008) Raija L.P. Lindberg et al. JOURNAL OF NEUROIMMUNOLOGY
- Progressive Multifocal Leukoencephalopathy
- (2008) Thomas Weber NEUROLOGIC CLINICS
- Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis
- (2008) M. Krumbholz et al. NEUROLOGY
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search